Citius Pharmaceuticals Scientific Advisory Board – New Jersey

The Citius Pharmaceuticals Scientific Advisory Board

Citius has assembled an internationally-renowned Scientific Advisory Board with a broad and deep range of experience in the areas of science and clinical development, along with experience working with the FDA. The members are passionate about innovation.


Dr. Issam Raad, MD

Issam Raad, MD
Scientific Advisory Board

Issam Raad, MD, is Chair of M.D. Anderson Cancer Center’s Department of Infectious Diseases and the Endowed Distinguished Professor of Medicine. Dr. Raad is the author of the underlying patents for Mino-Lok®.

Dr. Raad’s innovations in prevention of bloodstream infections have been endorsed at the highest level (Category 1A) by the Centers for Disease Control and Prevention (CDC). He has been widely honored for creative research and compassionate patient care, as well as outstanding mentorship and education. In 2015, Dr. Raad received the 2015 SHEA Mentor Scholar Award in recognition of his distinguished record over the last two decades in mentoring fellows and junior faculty, most of whom have assumed leadership positions as heads of infection control and prevention programs. In 2014, Dr. Raad received the outstanding “Gerald Bodey Distinguished Professor” award to honor his accomplishments in advancing the field of infections in cancer.


Dr. Mark Rupp, MD

Mark Rupp, MD
Scientific Advisory Board

Mark Rupp, MD, is a Professor and Chief of the Division of Infectious Diseases in the Department of Internal Medicine at the University of Nebraska Medical Center (UNMC). He also serves as the Medical Director of the Department of Infection Control & Epidemiology for Nebraska Medicine, the teaching hospital for UNMC.  More recently, Dr. Rupp has served as the Chief-of-Staff for Nebraska Medicine.  He is a Past President of SHEA and a Past President of ASM Division L (Infection Control/Hospital Epidemiology). Dr. Rupp has served as a consultant for the FDA, CDC, NIH, and VA.  Well-recognized for his skills as a teacher, researcher, and clinician, Dr. Rupp has published over 400 articles, chapters and abstracts.  He frequently presents papers at national and international meetings, serves as a guest lecturer, and is an active teacher and researcher.  Dr. Rupp’s research interests are in the areas of healthcare-associated infections and antimicrobial stewardship.


Dr. Leonard Mermel

Leonard A. Mermel, DO
Scientific Advisory Board

Leonard A. Mermel, DO, ScM, AM (Hon), FACP, FIDSA, FSHEA, is Professor of Medicine, Warren Alpert Medical School of Brown University, Adjunct Clinical Professor, University of Rhode Island College of Pharmacy, and Medical Director, Department of Epidemiology & Infection Control, Rhode Island Hospital. Dr. Mermel was a Technical Expert Panel Member of the Medicare Patient Safety Monitoring System, US Department of Health and Human Services. Dr. Mermel is also an elected member of Delta Omega, the Honorary Public Health Society. 

Dr. Mermel has been repeatedly selected by his peers to be included as one of The Best of Rhode Island - Infectious Diseases Physicians, Castle Connolly Top Doctors, Consumers’ Checkbook’s Top Doctors, US News & World Report Top Doctors, The Best Doctors in America, America’s Top Doctors, Guide to America’s Top Physicians, Marquis Top Doctors in America, and The Leading Physicians of the World. Dr. Mermel has co-authored US guidelines dealing with prevention and management of intravascular catheter infections, and has authored or co-authored over 300 articles, textbook chapters, and abstracts dealing with infection control and infectious diseases. Dr. Mermel and Dr. David Classen together developed the concept for the Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals, which is now a standard guidance used in the United States, and the basis for some of the National Patient Safety Goals.


Jesse Selber, M.D.

Jesse Selber, MD
Scientific Advisory Board

Jesse C. Selber, MD, MPH, FACS is the Director of Clinical Research and an Associate Professor in the Department of Plastic Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. A microvascular reconstructive surgeon, Dr. Selber’s research involves head and neck reconstruction, breast reconstruction, microsurgery, abdominal wall reconstruction, microsurgical training, robotic-assisted reconstructive surgery, and other areas. He also has an active robotic reconstructive surgery practice in which he developed and utilizes four different types of procedures. As a result of his work -- especially in the area of robotic-assisted microsurgery -- Dr. Selber has been invited to instruct and to perform surgical procedures at various national and international conferences. In addition, Dr. Selber has had over forty articles published in peer-reviewed journals and serves as a reviewer for several journals (e.g., Head and Neck Surgery, Annals of Plastic Surgery, etc.). He holds offices in multiple national plastic surgery societies, including the American Society of Reconstructive Microsurgery and the American Society of Plastic Surgeons, and is an Executive Board and Founding member of the Robotic Assisted Microvascular and Endoscopic Surgery society (RAMSES).


George M. Viola, M.D.

George M. Viola, MD, MPH
Scientific Advisory Board

George M. Viola, MD, is an Associate Professor of the Department of Infectious Diseases and the Clinical Medical Director of the Solid Cancer and Surgical-Related Infections Service at the University of Texas M.D. Anderson Cancer Center. He has published several peer-reviewed articles, mainly on the topic of device-related infections involving cardiac implantable electronic devices and breast implant and tissue expanders. Dr. Viola also holds a Master in Public Health in epidemiology from the University of Texas Health Science Center. Furthermore, he is board certified in Internal Medicine, Infectious Diseases, and Medical Quality.